Paper
31 January 2001 Using alpha-interferon as an adjunctive therapy to reduce the dose of energy required with photodynamic therapy in treating human bladder tumors: cell culture results
David Hall, Unyime O. Nseyo M.D., Dale Riggs, Barbara Jackson, Donald L. Lamm
Author Affiliations +
Abstract
Carcinoma in situ (CIS) of the bladder has long been known as an aggressive killer. Because of the high degree of progression to muscle invasion and the high rate of occult early metastasis, early radical cystectomy had been the preferred treatment, a highly morbid procedure. Even now, with routine use of continent diversions or oithotopic bladder replacements, most patients would agree that there is still a great deal of morbidity associated with this treatment.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
David Hall, Unyime O. Nseyo M.D., Dale Riggs, Barbara Jackson, and Donald L. Lamm "Using alpha-interferon as an adjunctive therapy to reduce the dose of energy required with photodynamic therapy in treating human bladder tumors: cell culture results", Proc. SPIE 4156, Clinical Lasers and Diagnostics, (31 January 2001); https://doi.org/10.1117/12.413705
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

Bladder

Tumors

Cell death

Carbon dioxide

Cancer

Diagnostics

Back to Top